Lei Xue - the First Affiliated Hospital of USTC, University of Science and Technology of China

基本信息

浏览量：7

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 30 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

CT-244 Updated Clinical Progress of IL-10 Expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses

Yugang Guo, Qianwen Xu,Lei Xue, Erlin Chen, Xuhan Zhang, Chonglin Liu,Min Gao, Youjia Li, Jingjing Ren, Karthik Sathiyanadan,Li Tang,Xingbing Wang

Clinical Lymphoma Myeloma and Leukemia (2024)

引用0浏览0引用

A Study of a New Mechanism: Intracellular Retention Allo-Cart Safety and Efficacy for Extranodal Bulky B-NHL

Jun Li, Liyun Yang,Xingbing Wang,Lei Xue, Rong Jin,Dan Liu, Tao Wang,Yulian Gao, Hongxing Ai, Jing Lei

Journal of Clinical Oncologyno. 16_suppl (2024): e19007-e19007

引用0浏览0引用

Updated Clinical Progress of IL-10 Expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses

Yugang Guo,Qianwen Xu,Lei Xue, Erlin Chen,Xuhan Zhang, Chonglin Liu,Min Gao, Youjia Li, Jingjing Ren, Karthik Sathiyanadan,Li Tang,Xingbing Wang

Clinical Lymphoma Myeloma & Leukemia (2024): S156-S156

引用0浏览0引用

Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF

Dan Liu,Juan Tong,Erling Chen,Li Wang,Lei Xue,Xuhan Zhang,Na Zhao, Xing Hu,Changcheng Zheng

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY (2024): 63-69

引用0浏览0WOS引用

Successfully Treatment of PLZF-RARα Positive Acute Promyelocytic Leukemia by Venetoclax Combining with Decitabine: a Case Report and Literature Review

Ziwei Zhou,Erling Chen, Jiqian Jiang,Lei Xue, Lijun Zhu,Xing Hu,Yingqiao Zhu,Changcheng Zheng,Juan Tong

HEMATOLOGYno. 1 (2024)

引用0浏览0WOS引用

Clinical validation and mechanistic insights of ThisCART: A novel allogeneic platform enhancing CAR-T signaling via intracellular TCRαβ/CD3 retention

Jun Li,Lei Xue,Sujun Li,Ling He,Kaichun Liu,Rong Jin,Tao Wang,Yinhang Zhang,Shanshan Chen, Yulian Gao,Dan Liu,Liyun Yang,Xingbing Wang

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

Abstract LB236: Metabolically Armed CD19 CAR-T Cells for Safe and Effective Treatment of Relapsed or Refractory CD19+ B Cell Hematological Malignancies at Extremely Low Doses

Yugang Guo,Qianwen Xu,Lei Xue,Erling Chen, Chonglin Liu,Min Gao, Youjia Li, Jingjing Ren, Jinping Li,Li Tang,Xingbing Wang

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Metabolically Armed CD19 CAR-T Cells for Safe and Effective Treatment of Relapsed or Refractory CD19+B Cell Hematological Malignancies at Extremely Low Doses

Yugang Guo, Qianwen Xu,Lei Xue,Erling Chen,Chonglin Liu,Min Gao, Youjia Li, Jingjing Ren,Jinping Li,Li Tang,Xingbing Wang

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

Abstract LB341: Clinical Validation and Mechanistic Insights of ThisCART: A Novel Allogeneic Platform Enhancing CAR-T Signaling Via Intracellular TCRαβ/CD3 Retention

Jun Li,Lei Xue,Sujun Li, Ling He,Kaichun Liu, Rong Jin,Tao Wang,Yinhang Zhang,Shanshan Chen, Yulian Gao, Dan Liu, Liyun Yang,Xingbing Wang

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Longitudinal Serum Proteomics Characterization of CD19-CAR-T Cell Therapy for B-Cell Malignancies

Youming Wang,Rui Sun,Weigang Ge,Lei Xue,Qianwen Xu,Hui Xu,Sujun Li,Miaomiao Wu,Tiannan Guo,Xingbing Wang

Journal of proteome research（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn